Women's cancer: Advancing molecular and immunotherapy

Curr Probl Cancer. 2017 Jan-Feb;41(1):7. doi: 10.1016/j.currproblcancer.2017.02.004.

Author

Oliver Dorigo¹

Affiliation

¹ Department of Obstetrics and Gynecology Stanford University School of Medicine, Stanford, CA. Electronic address: [email protected].

PMID: 28366203
DOI: 10.1016/j.currproblcancer.2017.02.004

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Antineoplastic Agents, Immunological / pharmacology
Antineoplastic Agents, Immunological / therapeutic use
Breast Neoplasms / genetics
Breast Neoplasms / immunology
Breast Neoplasms / therapy*
Cancer Vaccines / therapeutic use
Computational Biology
Costimulatory and Inhibitory T-Cell Receptors / antagonists & inhibitors
Costimulatory and Inhibitory T-Cell Receptors / immunology
Female
Genital Neoplasms, Female / genetics
Genital Neoplasms, Female / immunology
Genital Neoplasms, Female / therapy*
Humans
Immunotherapy / methods*
Molecular Targeted Therapy / methods

Substances

Antineoplastic Agents, Immunological
Cancer Vaccines
Costimulatory and Inhibitory T-Cell Receptors